September 10, 2019
October 23, 2019 | Inside Health Policy
An article published by Inside Health Policy quoted Aaron Josephson, Senior Director at ML Strategies, on Senators Elizabeth Warren (D-Mass.) and Bill Cassidy (R-La.) letter to U.S. Food and Drug Administration (FDA), requesting information about the FDA's upcoming guidance clarifying the distinction between remanufacturers and servicers.
September 26, 2019 | MedTechDive
MedTechDive reported that the U.S. Food and Drug Administration is not yet ready to go to Congress to seek new powers for its evolving precertification pilot for software, but it will need new authorities to determine how the experimental path fits into the current regulatory scheme. The article included commentary from Senior Director of ML Strategies Aaron Josephson and Mintz Associate Benjamin Zegarelli.
August 20, 2019 | Inside Health Policy
An article published by Inside Health Policy quoted Aaron Josephson, Senior Director at ML Strategies, extensively in response to recent debate surrounding the U.S. Food and Drug Administration’s proposed rule “Reporting Information Regarding Falsification of Data,” which was previously withdrawn.
August 14, 2019 | Boston Globe
The Boston Globe reported that the administration of Governor Charlie Baker has responded to data released by the Massachusetts Department of Transportation confirming that traffic congestion in the state has reached a “tipping point.” In the August 9 article, Senior Vice President of ML Strategies Stephen Silveira said that he supported the Baker administration’s prospective solution of opt-in toll lanes to ease traffic.
August 14, 2019 | WBUR
On August 12, Senior Vice President of ML Strategies Stephen Silveira was a guest on WBUR, Boston’s NPR News Station to discuss the Massachusetts Department of Transportation’s recent report on traffic congestion, as well as the Massachusetts Bay Transportation Authority’s plans to shut down key sections of the Red, Orange and Green Lines during weekends in the fall.